Zoonotic Disease Risk Assessment in Veterinary Practice

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Zoonotic risk assessment in veterinary practice is a structured process integrating patient history (signalment, origin, diet, outdoor access, wildlife contact), clinical presentation (fever of unknown origin, abortion, neurologic signs, vesicular lesions), and environmental factors (season, geography, housing, water sources, wildlife density) to determine the probability and consequences of pathogen transmission to humans.
• The assessment framework aligns with the One Health concept, acknowledging the interconnectedness of human, animal, and environmental health, and necessitates consideration of practice personnel, owners, household members, and the broader community.
• Clinical signs are risk modifiers, not definitive diagnostic endpoints; a comprehensive history, including owner occupation and household demographics (immunocompromised individuals, young children, pregnant women), carries significant weight, independent of the animal's physical examination findings.
• Risk is categorized into negligible, low, moderate, or high, dictating the level of personal protective equipment (PPE), diagnostic testing priorities, client education, and potential public health notification, with reassessment triggered by changes in clinical signs or exposure history.
• Biosecurity measures are tiered according to risk category, ranging from standard hand hygiene and disinfection to enhanced precautions (gloves, gowns, dedicated equipment) and isolation precautions (negative pressure ventilation, respirators) for high-risk patients.
• Documentation of the risk assessment, including the rationale for the assigned category and implemented mitigation measures, is critical for continuity of care and professional accountability, with regulatory reporting mandated for reportable zoonoses based on clinical suspicion and risk profile, not solely confirmed diagnosis.

Veterinary clinicians routinely encounter patients that may carry pathogens transmissible to humans. The clinical question is not whether a zoonotic hazard exists, but how to weigh the probability and consequences of transmission for a given patient, client, and practice context. This article provides a structured framework for assessing zoonotic risk in clinical settings, integrating patient history, clinical presentation, and environmental factors. It serves veterinary researchers and practitioners who need a reproducible method for risk stratification that can be applied across species and practice types.

The framework presented here draws on established principles from public health surveillance and international standard-setting bodies. The World Organization for Animal Health publishes international standards for animal health surveillance and trade-related disease control that inform veterinary risk assessment methodology WOAH terrestrial animal health standards. The World Health Organization has articulated a One Health framework linking human, animal, and environmental health for zoonotic disease control WHO One Health initiative. These sources provide the conceptual scaffolding for the practical assessment tools that follow.

At a Glance

Foundations of Zoonotic Risk Assessment

Zoonotic disease burden is distributed unevenly across populations and regions. In low-income countries, zoonoses and diseases that recently emerged from animals account for an estimated 26% of disability-adjusted life years lost to infectious disease, whereas in high-income countries the corresponding figure is less than 1% the multiple burdens of zoonotic disease and an Ecohealth approach to their assessment. This disparity shapes the priorities that veterinary risk assessment must serve. A risk framework developed for one setting cannot be assumed to transfer to another without recalibration.

The assessment of zoonotic risk operates at the interface of human and animal disease, and its impact and management fall across two sectors, which partly explains why these diseases are often neglected the multiple burdens of zoonotic disease and an Ecohealth approach to their assessment. Veterinary clinicians occupy a unique position at this interface. They are often the first professionals to encounter a zoonotic pathogen in an animal host, and their assessment determines whether human exposure is recognized and mitigated.

The Risk Assessment Logic

Risk assessment in this context follows a structured sequence. Hazard identification asks whether a pathogen with zoonotic potential is present or plausibly present in the patient. Exposure assessment evaluates the routes by which humans could acquire the pathogen from the animal or its environment. Consequence assessment considers the severity of human disease, including morbidity, mortality, and sequelae. Risk characterization integrates these components into a categorical judgment that can guide action.

This logic mirrors the semi-quantitative risk profiling methods used in national zoonoses prioritization exercises. Stakeholder-based approaches, such as the analytic hierarchy process used to prioritize 98 zoonoses in Japan, reveal that different groups weight risk factors differently. Researchers and public health officials in that exercise focused on case fatality as the chief factor, while physicians placed more weight on diagnosis and citizens on prevention stakeholder prioritization of zoonoses in Japan with analytic hierarchy process method. Veterinary clinicians should be aware that their own weighting of risk factors may differ from that of clients or public health authorities, and the assessment framework should make these weightings explicit.

The One Health Context

Zoonotic risk assessment in veterinary practice is a local application of the One Health concept. The WHO One Health initiative links human, animal, and environmental health for zoonotic disease control and antimicrobial resistance management WHO One Health initiative. The Centers for Disease Control and Prevention provides guidance and surveillance information on zoonotic disease prioritization, prevention, and cross-sector collaboration CDC One Health and zoonotic disease resources. For the individual clinician, this means that a risk assessment for a single patient should consider also the immediate client but also household contacts, practice staff, and the broader community.

The environmental dimension of zoonotic risk is particularly important in regions undergoing ecological transition. In northern North America and Greenland, for example, warming conditions are altering the distribution and transmission dynamics of zoonotic parasites. Temperature-dependent development of parasites in the environment means that climate change can shift both the geographic range and the seasonal windows of transmission risk tradition and transition: parasitic zoonoses of people and animals in Alaska, northern Canada, and Greenland. Veterinary risk assessments should therefore incorporate regional and seasonal ecological knowledge, also patient-level data.

History as the Primary Risk Instrument

The patient history is the most powerful tool in zoonotic risk assessment. A structured history should capture signalment, geographic origin and travel history, diet including raw or undercooked products, outdoor access, contact with wildlife or other domestic species, reproductive status and history, and vaccination status. For production animals, the history must extend to herd-level factors: source of animals, biosecurity practices, water sources, and contact with neighbouring herds or wildlife.

Occupational history of the owner and household members is equally important. Persons who work in slaughterhouses, farms, wildlife rehabilitation, or laboratories face elevated exposure risk. The presence of immunocompromised individuals, pregnant women, young children, or elderly persons in the household changes the consequence assessment for any given zoonotic pathogen. These individuals may experience more severe disease, and the risk threshold for intervention should be lowered accordingly.

Clinical Presentation as a Risk Modifier

Clinical signs that should raise the index of suspicion for zoonotic disease include fever of unknown origin, abortion or reproductive failure, neurologic signs, vesicular or ulcerative skin lesions, and acute respiratory disease. These presentations are not diagnostic of any specific zoonosis, but they should trigger a formal risk assessment before proceeding with routine handling, sample collection, or treatment.

The absence of clinical signs does not exclude zoonotic risk. Many zoonotic pathogens are carried asymptomatically by reservoir hosts. The history must therefore carry weight independent of the physical examination. A healthy puppy from a high-risk source may pose a greater zoonotic risk than a clinically ill animal from a low-risk source, depending on the pathogens in question.

Environmental and Regional Factors

Geographic location determines which zoonotic pathogens are endemic and therefore which risks are plausible. Regional surveillance data, where available, should inform the baseline risk for a given area. The World Health Organization has identified improved surveillance and interaction between the health, livestock, agriculture, natural resources, and wildlife sectors as macro-level priorities for zoonotic disease control research priorities for zoonoses and marginalized infections. Veterinary clinicians contribute to this surveillance function when they report suspect zoonotic cases to the appropriate authorities.

Seasonality modifies risk for pathogens with environmental transmission stages or vector-borne transmission. Tick activity, mosquito abundance, and environmental survival of parasite eggs and oocysts all vary seasonally. Housing type matters as well. Animals housed outdoors have greater exposure to wildlife and environmental contamination. Water sources, particularly surface water accessible to wildlife, can serve as a transmission link between domestic animals, wildlife, and humans.

Risk Categorisation and Documentation

The output of the assessment should be a categorical risk assignment: negligible, low, moderate, or high. This assignment should be based on explicit criteria and recorded in the medical record with the supporting rationale. The risk category determines the level of personal protective equipment used during handling, the need for diagnostic testing, client education content, and whether public health authorities should be notified.

Risk categorisation is an iterative process. A change in clinical signs, new information about exposure history, or a confirmed diagnosis of a notifiable pathogen should trigger reassessment. The initial assessment is a working hypothesis, not a final determination. This iterative logic aligns with the urgent need for iterative risk assessment strategies identified in national zoonoses prioritization work stakeholder prioritization of zoonoses in Japan with analytic hierarchy process method.

Structured Clinical Assessment Sequence

The clinical encounter proceeds through a defined sequence that converts history, examination findings, and environmental data into a risk category and a testing plan. The sequence is iterative. New information from diagnostic tests or repeated history taking can move a patient between categories, and the plan must be revised accordingly.

Step 1: Establish the Exposure Profile

Begin with the exposure history, which is the single most informative component of the assessment. Record the patient's species, breed, age, sex, and reproductive status, then document the following exposure domains:

• Animal contacts: species present in the household, contact with wildlife, livestock, or feral animals, recent acquisitions, boarding or grooming history, and bite or scratch incidents involving the patient or household members.
• Human contacts: occupation of owners and household members, pregnancy status, age of children, immunocompromised individuals, and any recent illness consistent with a zoonotic infection.
• Dietary history: raw meat or raw milk consumption, hunting or scavenging behavior, and access to carcasses.
• Travel history: patient travel and owner travel with or without the patient, with attention to incubation periods for relevant pathogens.
• Environmental exposures: water sources, soil contact, sandboxes, and proximity to agricultural operations.

The exposure profile is weighted by the local epidemiology. In northern North America and Greenland, for example, the relative importance of parasitic zoonoses differs markedly from temperate regions, with Echinococcus multilocularis, Toxoplasma gondii, and Trichinella ranking as priority concerns Jenkins et al., tradition and transition in parasitic zoonoses of the North. A history that is unremarkable in one region may be high risk in another.

Step 2: Score Clinical Presentation

Clinical signs are risk modifiers, not diagnostic endpoints. The same sign complex can carry different zoonotic weight depending on the exposure profile. Score the following categories:

• Gastrointestinal signs: diarrhea, vomiting, weight loss, with duration and character (hemorrhagic versus non-hemorrhagic, acute versus chronic).
• Dermatologic signs: alopecia, pruritus, crusting, nodules, or migratory lesions, with distribution and progression.
• Respiratory signs: cough, nasal discharge, dyspnoea, with acute or chronic onset.
• Neurologic signs: seizures, ataxia, behavioral change, cranial nerve deficits.
• Reproductive signs: abortion, stillbirth, orchitis, with timing relative to gestation.
• Systemic signs: fever, lethargy, lymphadenopathy, icterus.

Each sign category is assigned a score of 0 (absent), 1 (present but mild or non-specific), or 2 (present and characteriztic of a known zoonotic syndrome). A score of 2 in any category triggers enhanced biosecurity and a broader diagnostic panel. A score of 1 in multiple categories warrants the same response, because zoonoses frequently present with overlapping or atypical signs.

Step 3: Integrate Environmental and Regional Data

Environmental factors modify the interpretation of both history and clinical signs. Temperature-dependent development of parasites in the environment, changes in wildlife reservoir populations, and land-use patterns all shift the pretest probability of specific zoonoses Jenkins et al.. The clinician should maintain a working list of regionally endemic zoonoses and update it at least annually, drawing on CDC One Health and zoonotic disease resources and WOAH terrestrial animal health standards.

Seasonal factors matter. Vector-borne zoonoses peak with vector activity. Hunting season changes wildlife contact rates. Flooding and drought alter waterborne pathogen distribution. The assessment must therefore include the date and season, not as an administrative detail but as a variable that changes the differential diagnosis.

Step 4: Assign a Risk Category

The integrated assessment produces one of three risk categories:

The category is recorded in the medical record with the supporting evidence. The category is not static. A negative test result for a high-incubation pathogen does not downgrade the category until the incubation period has elapsed.

Diagnostic Prioritization

Testing is prioritized by the product of three factors: probability of exposure, severity of human disease if transmission occurs, and preventability of transmission. This framework follows the prioritization logic used in national zoonoses ranking exercises, where stakeholders weighted case fatality, diagnosis, and prevention differently depending on their professional perspective Kadohira et al., stakeholder prioritization of zoonoses with analytic hierarchy process. In clinical practice, the veterinarian must integrate these perspectives, because the physician managing a human case and the owner concerned about family safety will weigh the same pathogen differently.

Test Selection Criteria

Select tests based on the following hierarchy:

1. Sensitivity during the current clinical stage: serology is unreliable in acute infection before seroconversion, direct detection methods are preferred early.
2. Specimen type and timing: fecal examination for parasite stages requires fresh samples and may need repeated collection, molecular testing on blood or tissue has different windows.
3. Turnaround time: where human exposure has occurred, rapid testing is prioritized even at lower sensitivity.
4. Cost and availability: reference laboratory testing may be required for uncommon zoonoses, in-clinic testing is reserved for high-volume, validated assays.

Species differences change the correct choice. A dog with acute diarrhea and raw meat exposure warrants fecal antigen testing for Echinococcus species where endemic, while a cat with the same history warrants different parasite testing. Production animals require consideration of herd-level testing and WOAH terrestrial animal health standards for reportable diseases. Wildlife patients present additional constraints: sample collection may be limited to a single capture event, and the zoonotic risk to handlers may be higher than for domestic patients.

Biosecurity Implementation

Biosecurity measures are matched to the risk category and to the practical constraints of the practice setting.

Standard Precautions

All patients receive standard precautions: hand hygiene before and after contact, examination table disinfection between patients, and appropriate use of personal protective equipment (PPE) for procedures with splash or aerosol risk. These measures are the baseline and are not negotiable.

Enhanced Precautions

Moderate-risk patients receive enhanced precautions: dedicated examination room or designated area, gloves for all contact, and disinfection of all surfaces and equipment after use. Fecal and respiratory samples are handled in a biosafety cabinet where available. Client communication includes written instructions on household hygiene and symptom monitoring in human contacts.

Isolation Precautions

High-risk patients are isolated in a dedicated ward or room with negative pressure ventilation where available. PPE includes gown, gloves, and eye protection, with respirators for aerosol-generating procedures. Dedicated equipment remains in the isolation area. Waste is managed according to local biohazard regulations. Access is limited to essential personnel, and a log of all staff and client contacts is maintained.

The choice of biosecurity level is constrained by facility design. A single-room practice cannot achieve the same isolation capacity as a referral hospital. In such settings, the clinician must prioritize: the highest-risk patients are referred or managed with the maximum precautions the facility can support, and the limitations are documented in the medical record.

Documentation and Communication

The risk assessment is documented in the medical record as a structured entry that includes the exposure profile, clinical scores, environmental factors, assigned risk category, testing plan, and biosecurity measures. The documentation must be sufficient for another clinician to understand the reasoning without re-interviewing the owner.

Communication with the owner includes the risk category, the rationale, the testing plan, and the biosecurity measures required at home. Where human exposure has occurred, the owner is advised to consult a physician, and the veterinarian should offer to communicate directly with the physician. This cross-sector communication is a core function of the WHO One Health initiative, which links human, animal, and environmental health for zoonotic disease control.

Reportable zoonoses are reported to the appropriate public health and animal health authorities according to local requirements. The veterinarian should know the reporting list for their jurisdiction and should report suspected cases, also confirmed cases, where the clinical picture is compelling.

Recognized Failure Modes

The structured assessment sequence fails in predictable ways. The most consequential failure is premature closure, where the clinician assigns a risk category before completing the exposure profile. This typically occurs when a patient presents with a dramatic clinical sign that dominates attention, such as acute neurological disease, while the history of contact with bats, rodents, or unpasteurised dairy products remains uncollected. Detection of this failure requires a deliberate pause after history taking to confirm that all five exposure domains, species, contact type, duration, occupational context, and geographic origin, have been addressed.

A second failure mode is the anchoring of risk scores to the most recent case instead of to the current patient's data. Clinicians who recently managed a confirmed zoonotic infection tend to overestimate risk in subsequent similar presentations, while those who have never encountered a particular zoonosis tend to underestimate it. The corrective action is to apply the scoring criteria mechanically before adjusting for clinical judgment, and to record the score in the medical record before any modification.

A third failure involves the conflation of diagnostic testing with risk assessment. A negative test result does not lower the pre-test risk category, it only updates the probability of a specific pathogen. Clinicians who downgrade isolation precautions based on a single negative serological or fecal test expose staff and other patients to undetected infection during the window before seroconversion or intermittent shedding. The discriminating check is whether the risk category was assigned before testing and whether it remains in force until the clinical picture and test results are reconciled.

Common Errors and Corrective Actions

Less experienced clinicians frequently over-weight clinical presentation relative to history. A patient with no clinical signs but a documented bite from a rabies-vector species warrants a higher risk category than a patient with mild diarrhea and no exposure history. The corrective action is to treat the exposure profile as the primary determinant and clinical signs as modifiers, not the reverse.

Students often confuse risk to the human handler with risk to the animal patient. The assessment framework addresses both, but the scoring criteria differ. Human risk is driven by pathogen transmissibility, route of exposure, and the immune status of the exposed person. Animal risk is driven by the patient's own susceptibility and the potential for onward transmission within the practice. These must be scored separately and documented separately.

A further common error is the omission of occupational history for the owner or handler. A veterinarian assessing a dog from a farm must ask also about the dog's access to livestock but also about the owner's work with animals, since the owner may be the source of the dog's infection or the dog may be the source of the owner's infection. The corrective action is to include a standard occupational screen in every history, regardless of species.

Evidence Limitations and Divergent Expert Opinion

The evidence base for zoonotic risk assessment is uneven. The World Health Organization has identified research priorities for zoonoses affecting poor populations, noting that improved surveillance and cross-sector interaction are needed to support disease control (WHO research priorities for zoonoses and marginalized infections). However, the quantitative data needed to validate risk scoring systems are sparse for most zoonoses, particularly in low-income settings where the burden is highest (the multiple burdens of zoonotic disease and an Ecohealth approach).

Expert opinion differs on the appropriate weight to assign to environmental change. In northern North America, warming temperatures are shifting the distribution of temperature-dependent parasites, with water-borne protozoans such as Giardia and Cryptosporidium potentially emerging as more important causes of human disease (tradition and transition in parasitic zoonoses of the North). Some authorities argue that regional climate data should be a mandatory component of every risk assessment, while others maintain that the evidence does not yet support its inclusion outside known endemic zones.

Stakeholder disagreement extends to the prioritization of risk factors themselves. In a Japanese prioritization study using analytic hierarchy process methods, researchers and public health officials ranked case fatality as the most important factor, while physicians weighted diagnosis and citizens weighted prevention more heavily (stakeholder prioritization of zoonoses in Japan). This divergence has practical consequences: a risk assessment built for a research audience may not align with the concerns of the clinicians who must implement it.

Referral, Consultation, and Regulatory Reporting

Referral is indicated when the risk assessment identifies a pathogen that the practice cannot safely manage. This includes suspected high-consequence zoonoses such as rabies, viral hemorrhagic fevers, or transmissible spongiform encephalopathies, where diagnostic sampling, containment, and disposal exceed practice capacity. The WOAH terrestrial animal health standards provide the international framework for notification and trade-related measures, and the CDC One Health resources offer guidance on surveillance and cross-sector collaboration in the United States.

Laboratory involvement is warranted before confirmatory testing when the risk category is moderate or high, because sample selection, transport, and biosafety requirements vary by suspected pathogen. Consultation with a veterinary public health specialist or medical officer of health is appropriate when the exposure involves a human case, a foodborne outbreak, or a wildlife reservoir that cannot be contained.

Regulatory reporting obligations are triggered by the risk category, not by a confirmed diagnosis. A clinically compatible case with a high-risk exposure profile should be reported to the relevant authority while diagnostic confirmation is pending. The reporting threshold varies by jurisdiction and by pathogen, and the clinician is responsible for knowing the requirements of the local authority. Where uncertainty exists, a telephone call to the public health or veterinary authority is the appropriate first step, and it should be made before any samples are discarded or the patient is discharged.

Frequently Asked Questions

How Should I Prioritize Zoonotic Risks When Diagnostic Testing Is Limited by Cost or Access?

When resources are constrained, prioritize by the combination of exposure likelihood, clinical compatibility, and human health consequence. A patient with a compatible exposure history and clinical signs consistent with a high-consequence zoonosis warrants testing even when the pretest probability is modest. Conversely, a low-consequence pathogen with a low pretest probability can reasonably be deferred. Stakeholder-derived prioritization frameworks, such as the analytic hierarchy process used in Japan, show that case fatality and preventability consistently rank among the most important weighting criteria across professional groups. Document the reasoning behind any deferred testing so that the decision is auditable and can be revisited if the patient's condition or exposure context changes.

What Minimum Biosecurity Measures Are Acceptable When Ideal Isolation Facilities Are Unavailable?

When dedicated isolation housing is unavailable, the objective is to interrupt transmission through physical separation and workflow design. Use the most remote available cage or room, restrict access to essential personnel, and dedicate equipment such as bowls, litter trays, and examination tools to that patient. Apply enhanced precautions, including gloves, gowns, and eye protection, for any procedure that may generate aerosols or contact body fluids. Assign care tasks to the minimum number of staff and schedule them at the end of the day to reduce cross-exposure. The CDC One Health and zoonotic disease resources emphasize that layered administrative and environmental controls can partially compensate for infrastructure deficits when consistently applied.

Does the Risk Assessment Framework Change for Exotic or Wildlife Species?

The framework remains structurally identical, but the exposure profile and consequence scoring shift substantially. Wildlife species often carry pathogens with higher human pathogenicity because they have not been selected for reduced virulence through domestication. The exposure history must include capture method, source origin, and duration in captivity, as these determine which pathogens are plausible. Handling stress alters clinical presentation and may mask or mimic disease signs. Regional pathogen distributions are particularly influential for wildlife, as demonstrated in northern North America where parasite diversity and prevalence differ markedly from general populations. Consultation with a wildlife veterinarian or regional authority is advisable before assigning a risk category, because the evidence base for many wildlife-associated zoonoses is thinner than for domestic species.

What Should Be Recorded to Make a Zoonotic Risk Assessment Defensible in Retrospect?

The record must allow a second clinician to reconstruct the reasoning without relying on memory. Record the exposure history questions asked and the responses given, the clinical findings that informed the risk score, the environmental and regional data consulted, and the final risk category assigned. Note the specific precautions implemented and the rationale for any deviation from standard protocols. If testing was declined or deferred, record that discussion and the owner's decision. The AVMA practice resources provide guidance on medical record content that supports continuity of care and professional accountability. A contemporaneous record that distinguishes observed findings from interpreted risk is substantially more defensible than one completed retrospectively.

How Do I Explain a High-Risk Assessment to an Owner Without Causing Unnecessary Alarm?

Frame the conversation around actions instead of probabilities. State plainly that the patient's history and signs create a possibility of a disease transmissible to people, that the practice is taking specific precautions as a result, and that these precautions protect the owner and household as well as staff. Explain the testing plan and what the results will mean for the family's next steps. Avoid speculative discussion of worst-case outcomes before diagnostic confirmation. The WHO One Health Initiative recognizes that public perception substantially influences the effectiveness of zoonotic disease responses, so clear, proportionate communication is itself a control measure. Offer written guidance on symptom monitoring for household members and provide a direct contact point for questions.

When Should I Escalate a Case to Public Health Authorities instead of Managing It Internally?

Escalation is indicated when there is confirmed or strongly suspected infection with a reportable zoonotic pathogen, when a human household contact is already symptomatic, or when the exposure involves a setting with vulnerable people such as a school, care facility, or immunocompromised household member. When uncertain whether a condition is reportable, contact the relevant authority for advice before acting. The WOAH terrestrial animal health standards provide the international framework for notifiable disease reporting, while national authorities determine local requirements. Early consultation is preferable to delayed reporting, as the public health value of intervention declines rapidly once human exposure has occurred. Document the consultation and its outcome in the patient record.

Related Clinical & Scientific Guides

• Wildlife Disease Surveillance: Designing and Implementing a One Health Program
• Biosecurity Risk Assessment for Livestock Operations: A Practical Framework
• Rabies Post-Exposure Prophylaxis in Veterinary Personnel

References and Further Reading

• Research priorities for zoonoses and marginalized infections.. 2012.
• Tradition and transition: parasitic zoonoses of people and animals in Alaska, northern Canada, and Greenland.. 2013.
• The multiple burdens of zoonotic disease and an Ecohealth approach to their assessment.. 2012.
• Public health implications of emerging zoonoses.. 2000.
• Stakeholder prioritization of zoonoses in Japan with analytic hierarchy process method.. 2015.
• One world health: socioeconomic burden and parasitic disease control priorities.. 2013.
• WHO One Health Initiative. WHO.
• CDC One Health and Zoonotic Disease Resources. CDC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Zoonotic Disease Risk Communication in Veterinary Practice
• Veterinary Public Health and Wildlife Trade: Risk Assessment
• Food Safety Risk Assessment in Veterinary Practice
• Zoonotic Disease Risk Assessment in Animal Shelters: Protocols and Best Practices
• Wildlife Rehabilitation and Zoonotic Disease Risk: Protocols for Veterinary Professionals

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.